Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11468)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 21, 2016 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jácome AA, Coutinho AK, Lima EM, Andrade AC, Santos JSD. Personalized medicine in gastric cancer: Where are we and where are we going? World J Gastroenterol 2016; 22(3): 1160-1171 [PMID: 26811654 DOI: 10.3748/wjg.v22.i3.1160] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v22/i3/1160.htm |
| Number | Citing Articles |
| 1 |
Kazuhiro Sakuta, Yu Sasaki, Yasuhiko Abe, Hidenori Sato, Masakuni Shoji, Takao Yaoita, Makoto Yagi, Naoko Mizumoto, Yusuke Onozato, Takashi Kon, Ayumi Koseki, Sonoko Sato, Ryoko Murakami, Yuki Miyano, Yoshiyuki Ueno. Somatic alterations and mutational burden are potential predictive factors for metachronous development of early gastric cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-79195-0
|
| 2 |
Giulia Accordino, Sara Lettieri, Chandra Bortolotto, Silvia Benvenuti, Anna Gallotti, Elisabetta Gattoni, Francesco Agustoni, Emma Pozzi, Pietro Rinaldi, Cristiano Primiceri, Patrizia Morbini, Andrea Lancia, Giulia Maria Stella. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective. Cancers 2020; 12(8): 2105 doi: 10.3390/cancers12082105
|
| 3 |
Qichao Hu, Zhibei Li, Yubing Li, Xinyu Deng, Yuan Chen, Xiao Ma, Jinhao Zeng, Yanling Zhao. Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectives. Phytotherapy Research 2023; 37(6): 2661 doi: 10.1002/ptr.7866
|
| 4 |
Jia-Xing Zhang, Yi Xu, Ying Gao, Cui Chen, Zhou-San Zheng, Miao Yun, Hui-Wen Weng, Dan Xie, Sheng Ye. RETRACTED ARTICLE: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0586-y
|
| 5 |
Ke Ning, Yangguang Shao, Yuxin He, Fei Wang, Xi Cui, Furong Liu, Danni Li, Feng Li. Histone demethylase Jumonji domain‐containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt‐related transcription factor 3. Cancer Science 2020; 111(10): 3679 doi: 10.1111/cas.14594
|
| 6 |
Simona Laurino, Pellegrino Mazzone, Vitalba Ruggieri, Pietro Zoppoli, Giovanni Calice, Antonella Lapenta, Mario Ciuffi, Orazio Ignomirelli, Giulia Vita, Alessandro Sgambato, Sabino Russi, Geppino Falco. Cationic Channel TRPV2 Overexpression Promotes Resistance to Cisplatin-Induced Apoptosis in Gastric Cancer Cells. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.746628
|
| 7 |
Raquel Carvalho Montenegro, Alison Howarth, Alessandro Ceroni, Vita Fedele, Batoul Farran, Felipe Pantoja Mesquita, Martin Frejno, Benedict-Tilman Berger, Stephanie Heinzlmeir, Heba Z. Sailem, Roberta Tesch, Daniel Ebner, Stefan Knapp, Rommel Burbano, Bernhard Kuster, Susanne Müller. Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget 2020; 11(5): 535 doi: 10.18632/oncotarget.27462
|
| 8 |
Weilin Li, Chi Chun Wong, Xiaoming Zhang, Wei Kang, Geicho Nakatsu, Qinfu Zhao, Huarong Chen, Minnie Yin Yin Go, Philip Wai Yan Chiu, Xiaohong Wang, Jiafu Ji, Xiaona Li, Zongwei Cai, Enders Kwok Wai Ng, Jun Yu. CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis. Oncogene 2018; 37(50): 6383 doi: 10.1038/s41388-018-0402-1
|
| 9 |
Bo-Kyung Kim, Jae-Ho Cheong, Joo-Young Im, Hyun Seung Ban, Seon-Kyu Kim, Mi-Jung Kang, Jungwoon Lee, Seon-Young Kim, Kyung-Chan Park, Soonmyung Paik, Misun Won. PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer. Cancers 2019; 11(12): 1923 doi: 10.3390/cancers11121923
|
| 10 |
Paulina Stokłosa, Anna Borgström, Sven Kappel, Christine Peinelt. TRP Channels in Digestive Tract Cancers. International Journal of Molecular Sciences 2020; 21(5): 1877 doi: 10.3390/ijms21051877
|
| 11 |
Joschka Haltaufderheide, Sebastian Wäscher, Bernhard Bertlich, Jochen Vollmann, Anke Reinacher-Schick, Jan Schildmann. “I need to know what makes somebody tick …”: Challenges and Strategies of Implementing Shared Decision-Making in Individualized Oncology. The Oncologist 2019; 24(4): 555 doi: 10.1634/theoncologist.2017-0615
|
| 12 |
Qiang Li, Yugang Ge, Xiaofeng Chen, Lu Wang, Yiwen Xia, Zhipeng Xu, Zheng Li, Weizhi Wang, Li Yang, Diancai Zhang, Zekuan Xu. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer. Journal of Cellular Biochemistry 2019; 120(9): 15190 doi: 10.1002/jcb.28783
|
| 13 |
Liqiang Zhou, Shi H. Li, You Wu, Lin Xin. Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets. Cancer Medicine 2021; 10(10): 3309 doi: 10.1002/cam4.3654
|
| 14 |
Yaoyao He, Miao Yang, Rong Hou, Shuangquan Ai, Tingting Nie, Jun Chen, Huaifei Hu, Xiaofang Guo, Yulin Liu, Zilong Yuan. Preoperative prediction of perineural invasion and lymphovascular invasion with CT radiomics in gastric cancer. European Journal of Radiology Open 2024; 12: 100550 doi: 10.1016/j.ejro.2024.100550
|
| 15 |
Angela Buonadonna, Gian Maria Miolo, Valentina Fanotto, Federico Navarria, Elisa Palazzari, Claudio Belluco, Stefania Maiero, Vincenzo Canzonieri, Giulio Bertola, Antonino De Paoli. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 121 doi: 10.1007/978-3-030-04861-7_7
|
| 16 |
Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Emerson Lucena da Silva, Luina Benevides Lima, Lais Lacerda Brasil de Oliveira, Caroline Aquino Moreira-Nunes, William J. Zuercher, Rommel Mario Rodríguez Burbano, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro. Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer. Pharmaceutics 2022; 14(9): 1841 doi: 10.3390/pharmaceutics14091841
|
| 17 |
Philippe Taniere, Brendan O’Sullivan, Matthew Evans, Frances Hughes. Bancroft's Theory and Practice of Histological Techniques. 2019; : 395 doi: 10.1016/B978-0-7020-6864-5.00020-7
|
| 18 |
Zitong Wang, Yingying Chen, Xiaoyu Li, Yuhan Zhang, Xiaokun Zhao, Hao Zhou, Xuebo Lu, Lili Zhao, Qiang Yuan, Yunshu Shi, Jimin Zhao, Ziming Dong, Yanan Jiang, Kangdong Liu. Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2. Cancers 2022; 14(15): 3592 doi: 10.3390/cancers14153592
|
| 19 |
Yi Yang, Yi Nan, Yu-Hua Du, Shi-Cong Huang, Dou-Dou Lu, Jun-Fei Zhang, Xia Li, Yan Chen, Lei Zhang, Ling Yuan. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3. World Journal of Gastroenterology 2023; 29(27): 4317-4333 doi: 10.3748/wjg.v29.i27.4317
Abstract(351) |
Core Tip(311) |
Full Article(HTML)(1352)
|
Full Article with Cover (PDF)-13740K(56)
|
Full Article (Word)-5261K(33)
|
Audio-613K(1)
|
Peer-Review Report-224K(29)
|
Answering Reviewers-167K(33)
|
Full Article (PDF)-12625K(146)
|
Full Article (XML)-140K(43)
|
Times Cited (2)
|
Total Visits (3666)
|
Open
|
| 20 |
Wenjuan Zhou, Liying Ma, Jing Yang, Hui Qiao, Lingyu Li, Qian Guo, Jinlian Ma, Lijuan Zhao, Junwei Wang, Guozhong Jiang, Xiangbin Wan, Mariusz Adam Goscinski, Lina Ding, Yichao Zheng, Wencai Li, Hongmin Liu, Zhenhe Suo, Wen Zhao. Potent and specific MTH1 inhibitors targeting gastric cancer. Cell Death & Disease 2019; 10(6) doi: 10.1038/s41419-019-1665-3
|
| 21 |
Yalan Dai, Liqiong Yang, Abass Sakandar, Duoli Zhang, Fukuan Du, Xinyi Zhang, Linglin Zou, Yueshui Zhao, Jigang Wang, Zhenhua Zhang, Xu Wu, Mingxing Li, Xiao Ling, Lei Yu, Lishu Dong, Jing Shen, Zhangang Xiao, Qinglian Wen. Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.906197
|
| 22 |
Jiansong Ji, Weiqian Chen, Weishuai Lian, Ruijie Chen, Jinqing Yang, Qianqian Zhang, Qiaoyou Weng, Zia Khan, Jie Hu, Xi Chen, Peng Zou, Xiaoming Chen, Guang Liang. (S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival akt signal. Cell Death & Disease 2018; 9(6) doi: 10.1038/s41419-018-0667-x
|
| 23 |
Batoul Farran, Susanne Müller, Raquel C Montenegro. Gastric cancer management: Kinases as a target therapy. Clinical and Experimental Pharmacology and Physiology 2017; 44(6): 613 doi: 10.1111/1440-1681.12743
|
| 24 |
Xiaofeng Chen, Zhiqi Yang, Jiada Yang, Yuting Liao, Peipei Pang, Weixiong Fan, Xiangguang Chen. Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study. Cancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-00302-5
|
| 25 |
Omar Abdel-Rahman. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting. Expert Review of Gastroenterology & Hepatology 2018; 12(5): 525 doi: 10.1080/17474124.2018.1413348
|
| 26 |
Nicola Fusco, Silvano Bosari. <i>HER2</i> aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists. World Journal of Gastroenterology 2016; 22(35): 7926-7937 doi: 10.3748/wjg.v22.i35.7926
|
| 27 |
Chen Xu, Yalan Liu, Dongxian Jiang, Qian Li, Xiaowen Ge, Ying Zhang, Jie Huang, Jieakesu Su, Yuan Ji, Jun Hou, Shaohua Lu, Yingyong Hou, Tianshu Liu. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. Oncotarget 2017; 8(20): 33185 doi: 10.18632/oncotarget.16567
|
| 28 |
Junyong Weng, Jingbo Xiao, Yushuai Mi, Xu Fang, Yahuang Sun, Shanbao Li, Zhiwei Qin, Xu Li, Tingting Liu, Senlin Zhao, Lisheng Zhou, Yugang Wen. PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0189-y
|
| 29 |
Dan Zhang, Jiewen Zheng, Mengwei Ni, Jiarui Wu, Kuaihuan Wang, Xiaojiao Duan, Xiaomeng Zhang, Bing Zhang. Comparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysis. Oncotarget 2017; 8(40): 68873 doi: 10.18632/oncotarget.20320
|
| 30 |
Michelle D. Hackshaw, Christine L. Bui, Amy Ladner, Nora Tu, Zahidul Islam, Mary E. Ritchey, Maribel Salas. Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer. Cancer Treatment and Research Communications 2020; 24: 100189 doi: 10.1016/j.ctarc.2020.100189
|
| 31 |
Masashi Fukushima, Hirokazu Fukui, Jiro Watari, Chiyomi Ito, Ken Hara, Hirotsugu Eda, Toshihiko Tomita, Tadayuki Oshima, Hiroto Miwa. Gastric Xanthelasma, Microsatellite Instability and Methylation of Tumor Suppressor Genes in the Gastric Mucosa: Correlation and Comparison as a Predictive Marker for the Development of Synchronous/Metachronous Gastric Cancer. Journal of Clinical Medicine 2021; 11(1): 9 doi: 10.3390/jcm11010009
|
| 32 |
Sebahattin Celik, Remzi Kızıltan, Eyüp M Yılmaz, Özkan Yılmaz, Halit Demir. Potential diagnostic and prognostic significance of plasma prolidase activity in gastric cancer. Biomarkers in Medicine 2017; 11(4): 319 doi: 10.2217/bmm-2016-0367
|
| 33 |
Bryson W. Katona, Anil K. Rustgi. Gastric Cancer Genomics: Advances and Future Directions. Cellular and Molecular Gastroenterology and Hepatology 2017; 3(2): 211 doi: 10.1016/j.jcmgh.2017.01.003
|